XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
  UK
  USA
  World
  India
  South Africa
  New Zealand
  Australia
  Canada Healthcare
  China Healthcare
  Africa
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Australia Channel
subscribe to Australia newsletter

Medical News : Healthcare : Australia

   DISCUSS   |   EMAIL   |   PRINT
AMA Urges Paroxetine Users To Consult Their Doctors
Sep 7, 2005, 23:52, Reviewed by: Dr.

The decision comes after a Danish study and an unpublished US study both indicate an increased risk of cardiovascular defects in children born to women taking Paroxetine.

 
The AMA(australia) is today alerting its members of a decision by pharmaceutical company, GlaxoSmithKline (GSK), to strengthen its warning against the use of Paroxetine for the treatment of depression in women contemplating pregnancy or in the first trimester of pregnancy.

The AMA(australia) advises patients not to worry and to seek immediate advice from their doctor.

A national response to inform patients has been prepared by the Therapeutic Goods Administration (TGA).

The decision comes after a Danish study and an unpublished US study both indicate an increased risk of cardiovascular defects in children born to women taking Paroxetine.

Paroxetine is classified as a Selective Serotonin Reuptake Inhibitors (SSRI).

The TGA advises that in Australia Paroxetine is registered under the trade names Aropax, Oxetine, Paxtine, Chem mart, GenRx and Terry White Chemists Paroxetine, Paroxetine-RL, Paroxetine-BC, Paroxetine Hexal, Espar, Loxamine, Paroxat CR, and Ausrox.

The identified problem is ventricular septal defects, which can occur also in non-SSRI users. It is a common, benign malformation that mostly resolves itself and may not even be diagnosed.

Authorities in the US and Australia stress that the problem is confined to Paroxetine and is not generalised to all SSRIs.

The GSK decision affects women on Paroxetine who are contemplating pregnancy, or who are in their first trimester of pregnancy.

It is important that women do not suddenly stop taking their Paroxetine. They must contact their doctor – GP, psychiatrist or obstetrician/gynaecologist – as soon as possible to seek advice about stopping their medication safely.
 

- Australian Medical Association (AMA)
 

www.ama.com.au

 
Subscribe to Australia Newsletter
E-mail Address:

 

Women interested in participating in the treatment study may contact McCrady and Epstein and their colleagues at (732)-445-0900. More information about the Rutgers Women’s Treatment Project is available at womenandalcohol.rutgers.edu.

Related Australia News

Gardasil to be available in Australia by the end of 2006
Plump Australian kids urged to get out more
"Take Panic Out of Bird Flu Pandemic"
Involve GPs in Frontline Response To Possible Flu Pandemic
AMA Urges Paroxetine Users To Consult Their Doctors
World No Tobacco Day Puts Health Professionals in the Spotlight
Health System Review Must Be Based on the Medical Model, Not the Economic Model
Health Resources Must Go To Patients
AMA Calls for Transparency of Mental Health Services in Australia's Detention Centres
General Practice Nurses Make Perfect Sense


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us